The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13.8 million single-award indefinite delivery/indefinite quantity (IDIQ) contract to American Regent Inc., a pharmaceutical manufacturer and distributor, to provide various pharmaceuticals to support military medical treatment facilities worldwide. The contract, which runs through September 2031, enables American Regent to deliver critical injectable medications, including atropine sulfate, glycopyrrolate, and hydroxyzine, through firm-fixed-price delivery orders. American Regent also holds a $131.4 million multiple award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs to supply hematology-related pharmaceutical products. The DLA contract does not have any set-aside designations, indicating American Regent's ability to compete in full and open competition. The company specializes in injectable drugs and sterile pharmaceutical preparations, and has consistently supplied essential medications to the U.S. government through various federal contract vehicles. The task orders issued under the DLA IDIQ contract demonstrate American Regent's role in providing a range of pharmaceutical products to military healthcare programs. Delivery orders have primarily focused on the supply of injectable medications such as atropine sulfate, glycopyrrolate, and hydroxyzine, with the majority of the deliveries being made from the company's facility in East Yaphank, New York. These firm-fixed-price contracts, typically ranging from a few hundred to tens of thousands of dollars, support the DLA Troop Support Medical's mission to maintain medical readiness and deliver critical pharmaceuticals to military medical treatment facilities worldwide.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00011 | Exercise an Option | $0 | 12/19/24 | |
| P00010 | Other Administrative Action | $0 | 9/24/24 | |
| P00009 | Other Administrative Action | $0 | 5/28/24 | |
| P00008 | Exercise an Option | $0 | 10/19/23 | |
| P00007 | Other Administrative Action | $0 | 9/21/23 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order SPE2D021D0008-SPE2D323F232P | American Regent Inc. | $185 | 9/19/23 | 9/22/23 | 9/19/23 | |
Delivery Order SPE2D021D0008-SPE2D323F166H | American Regent Inc. | $185 | 8/24/23 | 8/29/23 | 8/24/23 | |
Delivery Order SPE2D021D0008-SPE2D323F095G | American Regent Inc. | $1.7k | 7/26/23 | 7/31/23 | 7/26/23 | |
Delivery Order SPE2D021D0008-SPE2D324F138F | American Regent Inc. | $29.6k | 7/22/24 | 7/25/24 | 7/22/24 | |
Delivery Order SPE2D021D0008-SPE2D324F9821 | American Regent Inc. | $28.7k | 5/16/24 | 5/21/24 | 5/16/24 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
PHARMACEUTICAL CEC AWARD | SPE2D015R0002 | Defense Logistics Agency Troop Support Medical | Award Notice 1/2 | 8/13/15, 11:24 AM | |
On September 11, 2017, Medical Readiness awarded a Pharmaceutical contract to Alvogen, Inc. for fourteen (14) product lines | SPE2D015R0002 | Defense Logistics Agency Troop Support Medical | Award Notice 2/2 | 9/11/17, 11:03 AM |